Cummins India – Q2 FY25 Earnings Highlights
Cummins India delivered a strong beat across all key metrics, supported by robust demand momentum, improved product mix, and better cost efficiencies.
| Metric | Actual | Estimate | Miss/Beat | YoY Change | YoY Base |
|---|---|---|---|---|---|
| Net Profit | ₹937 Cr | ₹512.3 Cr | Beat | ▲ 41.3% | ₹451 Cr |
| Revenue | ₹3,170 Cr | ₹2,811 Cr | Beat | ▲ 27.2% | ₹2,492 Cr |
| EBITDA | ₹695 Cr | ₹563.9 Cr | Beat | ▲ 44.5% | ₹481 Cr |
| EBITDA Margin | 21.9% | 20.1% | Beat | ▲ vs 19.3% | 19.3% |
Verdict
Cummins posted a clear earnings beat on both revenue and profitability, with margins expanding sharply YoY. Strong operational execution and sustained demand visibility indicate continued momentum ahead.
Lupin – Q2 FY25 Earnings Highlights (With Estimates)
Lupin delivered a strong beat on revenue, profitability, and margins, led by robust U.S. business performance, improved product mix, and cost efficiencies.
| Metric | Actual | Estimate | YoY | Beat/Miss |
|---|---|---|---|---|
| Net Profit | ₹1,478 Cr | ₹1,217.8 Cr | ▲ 73.3% (₹852.6 Cr) | Beat |
| Revenue | ₹7,047.5 Cr | ₹6,559.4 Cr | ▲ 24.2% (₹5,672.7 Cr) | Beat |
| EBITDA | ₹2,341.7 Cr | ₹1,774.2 Cr | ▲ 74.7% (₹1,340.5 Cr) | Beat |
| EBITDA Margin | 33.2% | 27% | ▲ (YoY: 23.6%) | Beat |
Verdict
A strong all-round beat with significant margin expansion and robust profitability. U.S. market traction and operational efficiencies drove outperformance. Sustenance of margins and regulatory progress remain key ahead.
Apollo Hospitals – Q2 FY25 Earnings Highlights
| Metric | Actual | Estimate | YoY Change | YoY Base | Beat / Miss |
|---|---|---|---|---|---|
| Net Profit | ₹494 Cr | ₹426.6 Cr | ▲ 25% | ₹395 Cr | Beat |
| Revenue | ₹6,303 Cr | ₹6,231.7 Cr | ▲ 12.8% | ₹5,589 Cr | Beat |
| EBITDA | ₹941 Cr | ₹877.8 Cr | ▲ 15.4% | ₹815.7 Cr | Beat |
| EBITDA Margin | 14.9% | 14.1% | ▲ from 14.6% | 14.6% | Beat |
Verdict
Apollo delivered a clear earnings beat with strong revenue traction, higher patient volumes and efficient cost management. Margin expansion reflects better case mix and improving operating leverage. Demand visibility remains solid with stable profitability outlook.
ABB India – Q3 CY25 Earnings Highlights
| Metric | Actual | Estimate | YoY | YoY Base | Miss/Beat |
|---|---|---|---|---|---|
| Revenue | ₹3,310 Cr | ₹3,175.73 Cr | ▲ 13.7% | ₹2,912 Cr | Beat |
| EBITDA | ₹500 Cr | ₹495.5 Cr | ▼ 7.4% | ₹540 Cr | In-line |
| Net Profit | ₹409 Cr | ₹413.3 Cr | ▼ 7.3% | ₹441 Cr | Miss |
| Operating Margin | 15.1% | 16% | ▼ from 18.5% | 18.5% | Miss |
Verdict
ABB India delivered strong revenue growth driven by healthy execution and robust demand. However, margins weakened, impacting profitability. The company beat on revenue, remained in-line on EBITDA, but missed expectations on net profit and margins.
Overall: Growth is intact, but margin pressure remains the key monitorable going forward.
Chola Investment – Q2 Earnings Highlights
| Metric | Actual | Estimate | Miss / Beat |
|---|---|---|---|
| Net Profit | ₹1,155 Cr | ₹1,170 Cr | ▼ Miss |
| NII (Net Interest Income) | ₹3,378 Cr | ₹3,359 Cr | ▲ Beat |
| PPoP (Pre-Provision Operating Profit) | ₹2,458 Cr | ₹2,482 Cr | ▼ Miss |
| Provisions | ₹897 Cr | ₹907 Cr | ▲ Beat |
Asset Quality
| Metric | Q2 | QoQ Change | YoY Change |
|---|---|---|---|
| GNPA | 3.35% | ▼ (vs 3.16%) | ▼ (vs 2.83%) |
| NNPA | 1.93% | ▼ (vs 1.80%) | ▼ (vs 1.59%) |
Verdict
Chola delivered a steady operational quarter, with NII performance and loan growth remaining healthy. However, profitability came slightly below expectations due to marginally higher credit costs and softer PPoP. Asset quality saw a small sequential uptick, but remains manageable and broadly stable.
Godrej Properties – Q2 FY26 (Sep 2025) Earnings Highlights
Price: ₹2,194 | M.Cap: ₹66,099 Cr | PE: 42.7
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹740 Cr | ▼ 32% | ₹1,093 Cr | ▲ 70% | ₹435 Cr |
| EBITDA | -₹596 Cr | ▼ vs Profit | ₹28.8 Cr Profit | ▼ Loss Widened | -₹270 Cr |
| Net Profit | ₹403 Cr | ▲ 21% | ₹334 Cr | ▼ 33% | ₹598 Cr |
| EPS | ₹13.45 | ▲ 12% | ₹12.06 | ▼ 32% | ₹19.92 |
Operational Highlights
- Booking Value surged ▲ 64% YoY and ▲ 20% QoQ to ₹8,505 Cr – strong demand across key micro-markets.
- Achieved 48% of full-year FY26 guidance in H1 – tracking ahead of planned trajectory.
- FY26 Booking Value guidance reaffirmed at ₹32,500 Cr with potential upside.
- Collections grew ▲ 2% YoY and ▲ 11% QoQ to ₹4,066 Cr – maintaining strong cash flow discipline.
Verdict
Godrej Properties demonstrated strong operational momentum with robust bookings and healthy collections, reinforcing its market leadership in premium housing. While profitability appears volatile due to accounting and cost timing, the underlying business performance remains solid. The company is well-positioned to meet or exceed its FY26 growth guidance.
Amara Raja Energy – Q2 FY26 Earnings Highlights
Price: ₹989 | Market Cap: ₹18,098 Cr | PE: 22.4
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹3,388 Cr | ▲ 8% | ₹3,136 Cr | ▲ 1% | ₹3,350 Cr |
| EBITDA | ₹406 Cr | ▼ 8% | ₹441 Cr | ▲ 5% | ₹387 Cr |
| Net Profit | ₹302 Cr | ▼ 12% | ₹341 Cr | ▲ 56% | ₹194 Cr |
| EPS | ₹16.52 | ▲ 26% | ₹13.15 | ▲ 56% | ₹10.60 |
Verdict
Amara Raja posted stable revenue growth supported by consistent demand across automotive and industrial battery segments. While EBITDA and net profit declined YoY due to input cost and margin pressure, the QoQ recovery highlights improving operating efficiency. EPS saw strong YoY growth due to better profitability and tax efficiency.
Zydus Lifesciences – Q2 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹6,123 Cr | ▲ 17% | ₹5,237 Cr | ▼ 7% | ₹6,574 Cr |
| EBITDA | ₹2,016 Cr | ▲ 38% | ₹1,461 Cr | ▼ 3% | ₹2,088 Cr |
| Net Profit | ₹1,239 Cr | ▲ 41% | ₹920 Cr | ▼ 19% | ₹1,521 Cr |
| EPS | ₹12.51 | ▲ 38% | ₹9.06 | ▼ 14% | ₹14.58 |
Overall View
Zydus Lifesciences delivered strong year-on-year growth across revenue, EBITDA, and net profit, reflecting solid operational execution and sustained demand momentum. The sequential cooling is mainly due to a high base from the previous quarter and does not dilute the underlying business strength.
Verdict
Positive long-term momentum remains intact. Robust portfolio, margin discipline, and steady execution continue to support the growth outlook. The QoQ dip appears temporary and not a structural weakness.
Hindustan Construction – Q2 (Sep 2025) Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹961 Cr | ▼ 32% | ₹1,407 Cr | ▼ 12% | ₹1,091 Cr |
| EBITDA | ₹146 Cr | ▼ 40% | ₹242 Cr | ▼ 18% | ₹179 Cr |
| Net Profit | ₹47.8 Cr | ▼ 25% | ₹63.9 Cr | ▼ 6% | ₹50.7 Cr |
| EPS | ₹0.26 | ▼ 32% | ₹0.38 | ▼ 7% | ₹0.28 |
Verdict
Hindustan Construction reported a weak quarter with revenue and profitability declining both YoY and QoQ. Execution delays and margin pressures continued to weigh on earnings. However, the moderation in net profit decline vs revenue suggests some cost controls in place. Sustained order inflows and execution pickup remain key to any meaningful improvement ahead.
Integra Engineering – Q2 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹41.0 Cr | ▼ 1% | ₹41.5 Cr | ▼ 10% | ₹45.7 Cr |
| EBITDA | ₹6.49 Cr | ▼ 24% | ₹8.53 Cr | ▼ 29% | ₹9.08 Cr |
| Net Profit | ₹3.47 Cr | ▼ 35% | ₹5.31 Cr | ▼ 32% | ₹5.08 Cr |
| EPS | ₹1.01 | ▼ 35% | ₹1.55 | ▼ 32% | ₹1.48 |
Verdict
The quarter remained soft with declines in revenue and profitability on both YoY and QoQ basis. Margin pressure was visible, reflecting weaker operating leverage. A recovery ahead may depend on improvement in execution pace and better cost control.
Birlasoft – Q2 (Sep 2025) Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹1,329 Cr | ▼ 3% | ₹1,368 Cr | ▲ 3% | ₹1,285 Cr |
| EBITDA | ₹214 Cr | ▲ 30% | ₹165 Cr | ▲ 35% | ₹159 Cr |
| Net Profit | ₹116 Cr | ▼ 9% | ₹128 Cr | ▲ 9% | ₹106 Cr |
| EPS | ₹4.17 | ▼ 10% | ₹4.61 | ▲ 9% | ₹3.83 |
Verdict
Q2 reflects healthy margin recovery with strong QoQ profitability improvement driven by disciplined cost management and better operational efficiency. However, revenue growth remains muted on a YoY basis, indicating softer demand trends in certain verticals. Sustaining deal wins and accelerating pipeline execution will be critical for revenue momentum in upcoming quarters.
Triveni Engineering & Industries – Q2 (Sep 2025) Earnings Highlights
CMP: ₹357 │ M.Cap: ₹7,824 Cr │ PE: 29.9x
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹1,706 Cr | ▲ 14% | ₹1,491 Cr | ▲ 7% | ₹1,598 Cr |
| EBITDA | ₹66.1 Cr | ▲ 1343% | ₹4.58 Cr | ▲ 24% | ₹53.4 Cr |
| Net Profit | ₹21.4 Cr | ▲ 235% | -₹22.4 Cr | ▲ 919% | ₹2.10 Cr |
| EPS | ₹1.18 | ▲ 234% | -₹0.88 | ▲ 5.9x | ₹0.20 |
Verdict
Triveni delivered a strong turnaround quarter with sharp recovery in profitability and margin expansion. QoQ performance shows clear operational momentum. Sustaining margins and ensuring volume visibility will be the key monitorables going ahead.
Bombay Dyeing – Q2 (Sep 2025) Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Revenue | ₹363 Cr | ▼ 5% | ₹381 Cr | ▼ 4% | ₹378 Cr |
| EBITDA | -₹12.7 Cr | Loss narrowed | -₹41.8 Cr | Loss improved | -₹14.0 Cr |
| Net Profit | ₹1.92 Cr | ▼ (High base last year) | ₹393 Cr* | ▼ | ₹13.8 Cr |
| EPS | ₹0.09 | ▼ (High one-time gains base) | ₹19.03 | ▼ | ₹0.67 |
*Includes exceptional one-time gain in Q2 FY25.
Verdict
Bombay Dyeing continues to show structural operational recovery, with EBITDA losses narrowing for the second consecutive quarter. However, topline softness and normalization of one-off gains impacted year-on-year comparisons. Sustained margin discipline and a gradual pickup in demand will be essential to drive earnings momentum going forward.
Mankind Pharma – Q2 (Sep 2025) Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Revenue | ₹3,697 Cr | ▲ 21% | ₹3,061 Cr | ▲ 4% | ₹3,570 Cr |
| EBITDA | ₹921 Cr | ▲ 9% | ₹847 Cr | ▲ 9% | ₹847 Cr |
| Net Profit | ₹520 Cr | ▼ 22% | ₹659 Cr | ▲ 17% | ₹445 Cr |
| EPS | ₹12.39 | ▼ 24% | ₹16.31 | ▲ 17% | ₹10.62 |
Verdict
Mankind Pharma posted solid revenue growth YoY and QoQ, supported by strong branded formulations performance. EBITDA remained stable with margin improvement QoQ. However, Net Profit and EPS declined YoY due to higher tax outgo and lower other income. Sequential recovery in profitability suggests underlying operational momentum is healthy, though valuations largely reflect the growth outlook.
Jay Bharat Maruti – Q2 (Sep 2025) Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Revenue | ₹583 Cr | ▲ 5% | ₹555 Cr | ▲ 5% | ₹557 Cr |
| EBITDA | ₹61.4 Cr | ▲ 80% | ₹34.1 Cr | ▼ 7% | ₹65.8 Cr |
| Net Profit | ₹18.0 Cr | ▲ 503% | ₹2.99 Cr | ▼ 22% | ₹23.1 Cr |
| EPS | ₹1.67 | ▲ 496% | ₹0.28 | ▼ 22% | ₹2.13 |
Valuation Snapshot
Price: ₹97.4 | Market Cap: ₹1,069 Cr | PE: ~16.6x
Verdict
Jay Bharat Maruti posted strong year-on-year growth driven by margin expansion and operational efficiency. However, the sequential dip in EBITDA and profitability indicates normalization after an unusually strong June quarter. Sustainability of margins will depend on raw material trends, demand momentum from Maruti Suzuki, and scale efficiencies ahead.
Hind Rectifiers – Q2 FY26 Earnings Highlights
Price: ₹1,841 | M.Cap: ₹3,172 Cr | PE: 66.5
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹227 Cr | ▲ 37% | ₹166 Cr | ▲ 6% | ₹215 Cr |
| EBITDA | ₹25.9 Cr | ▲ 41% | ₹18.3 Cr | ▲ 7% | ₹24.3 Cr |
| Net Profit | ₹14.8 Cr | ▲ 45% | ₹10.2 Cr | ▲ 16% | ₹12.8 Cr |
| EPS | ₹8.58 | ▲ 44% | ₹5.95 | ▲ 15% | ₹7.46 |
Verdict
Hind Rectifiers continues to deliver strong growth, supported by sustained demand and improving profitability. Margin expansion and sequential earnings momentum reflect improving operational efficiency and a positive business outlook.
UPL – Q2 (Sep 2025) Earnings Highlights
Price: ₹733 | M.Cap: ₹61,849 Cr | PE: 11.8
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹12,019 Cr | ▲ 8% | ₹11,090 Cr | ▲ 30% | ₹9,216 Cr |
| EBITDA | ₹4,428 Cr | ▲ 29% | ₹3,420 Cr | ▲ 22% | ₹3,626 Cr |
| Net Profit | ₹612 Cr | ▲ Turnaround | -₹585 Cr | ▲ Turnaround | -₹176 Cr |
| EPS | ₹6.56 | ▲ From -₹5.25 | -₹5.25 | ▲ From -₹1.04 | -₹1.04 |
Management Guidance Update
- FY26 EBITDA growth guidance raised to 12–16% (earlier 10–14%)
- FY26 Revenue growth guidance maintained at 4–8%
- Focus on working capital reduction, cash flow improvement & margin strengthening
Verdict
UPL posted a strong recovery quarter with meaningful operational improvement and a clear return to profitability. The increase in EBITDA guidance signals management confidence in demand visibility and continued cost discipline. Sequential momentum suggests that the business cycle has likely bottomed out and an uptrend is underway.
Clean Science – Q2 FY26 (Sep 2025) Earnings Highlights
Price: ₹981 | M.Cap: ₹10,415 Cr | PE: 35.4
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹211 Cr | ▼ 7% | ₹228 Cr | ▼ 4% | ₹220 Cr |
| EBITDA | ₹90.0 Cr | ▼ 5% | ₹94.6 Cr | ▼ 11% | ₹101 Cr |
| Net Profit | ₹64.6 Cr | ▼ 4% | ₹67.4 Cr | ▼ 16% | ₹76.6 Cr |
| EPS | ₹6.08 | ▼ 4% | ₹6.35 | ▼ 16% | ₹7.21 |
Verdict
Clean Science reported a subdued quarter with declines both YoY and QoQ across revenue and profitability, driven by softer demand and lower realizations in key product segments. While margins remained relatively stable, lower volumes impacted operating leverage and sequential profitability. Recovery ahead will depend on improvement in end-market demand and better capacity utilization.
Flair Writing – Q2 FY26 Earnings Highlights
Price: ₹330 | M.Cap: ₹3,481 Cr | PE: 29.5
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹263 Cr | ▲ 9% | ₹242 Cr | ▲ 9% | ₹242 Cr |
| EBITDA | ₹42.9 Cr | ≈ Flat | ₹43.0 Cr | ▲ 13% | ₹38.0 Cr |
| Net Profit | ₹36.5 Cr | ▲ 14% | ₹32.0 Cr | ▲ 35% | ₹27.1 Cr |
| EPS | ₹3.46 | ▲ 14% | ₹3.03 | ▲ 35% | ₹2.57 |
Verdict
Flair Writing delivered a solid quarter with strong QoQ improvement in EBITDA and profitability, while YoY growth remained healthy. Margin recovery and operating leverage supported earnings expansion. Demand trends remain stable heading into the festive and academic seasons, maintaining positive business outlook.
Dam Capital Advisors – Q2 (Sep 2025) Earnings Highlights
Price: ₹255 | M.Cap: ₹1,800 Cr | PE: 16.0
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹107 Cr | ▲ 69% | ₹63.3 Cr | ▲ 247% | ₹30.8 Cr |
| EBITDA | ₹75.9 Cr | ▲ 124% | ₹33.9 Cr | ▲ 1,178% | ₹5.94 Cr |
| Net Profit | ₹52.1 Cr | ▲ 140% | ₹21.7 Cr | ▲ Turnaround | ₹0.16 Cr |
| EPS | ₹7.37 | ▲ 140% | ₹3.07 | ▲ Turnaround | ₹0.02 |
Verdict
Dam Capital delivered an exceptionally strong quarter, showcasing robust revenue growth, sharp margin expansion, and a solid profitability turnaround. The strong QoQ momentum reflects improved deal flow and disciplined cost management. If broader market activity stays supportive, growth traction is likely to continue.
Ceinsys Tech – Q2 (Sep 2025) Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹163 Cr | ▲ 82% | ₹90 Cr | ▲ 4% | ₹157 Cr |
| EBITDA | ₹35.6 Cr | ▲ 113% | ₹16.8 Cr | ▲ 18% | ₹30.3 Cr |
| Net Profit | ₹25.7 Cr | ▲ 121% | ₹11.6 Cr | ▼ vs ₹31.6 Cr | ₹31.6 Cr |
| EPS | ₹14.43 | ▲ 116% | ₹6.68 | ▼ vs ₹18.14 | ₹18.14 |
Verdict
Ceinsys Tech delivered strong YoY growth across revenue, EBITDA, net profit, and margins, driven by robust execution in government and infra-tech projects. QoQ profit dipped due to higher tax/quarterly expense timing, but the underlying business momentum and order pipeline remain firm, supporting a positive growth outlook.
Kabra Extrusion – Q2 (Sep 2025) Earnings Highlights
Price: ₹239 | M.Cap: ₹842 Cr | PE: 223.4
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹135 Cr | ▲ 5% | ₹128 Cr | ▲ 57% | ₹86 Cr |
| EBITDA | ₹8.97 Cr | ▼ 59% | ₹22 Cr | Turnaround | -₹2.97 Cr |
| Net Profit | ₹0.33 Cr | ▼ 97% | ₹12.3 Cr | Turnaround | -₹7.61 Cr |
| EPS | ₹0.09 | ▼ 97% | ₹3.53 | Improved | -₹2.18 |
Verdict
Kabra Extrusion delivered a strong QoQ revenue rebound, driven by renewed demand and better execution. However, margins and profitability continue to remain significantly weaker on a YoY basis due to higher input costs and lower operating leverage. While the sequential improvement is encouraging, sustained margin recovery is essential for a meaningful earnings revival ahead.
Amber Enterprises – Q2 FY26 Earnings Highlights
Price: ₹7,832 | M.Cap: ₹27,486 Cr | PE: 123.3
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹1,647 Cr | ▼ 2% | ₹1,685 Cr | ▼ 52% | ₹3,449 Cr |
| EBITDA | ₹83.8 Cr | ▼ 25% | ₹111 Cr | ▼ 66% | ₹250 Cr |
| Net Profit | –₹32.2 Cr (Loss) | ▼ 271% | ₹21 Cr Profit | ▼ from Profit | ₹106 Cr Profit |
| EPS | –₹9.35 | ▼ 264% | ₹5.69 | ▼ from ₹30.66 | ₹30.66 |
Verdict
Amber Enterprises reported a weak seasonal quarter with a steep QoQ decline in revenue and profitability due to lower demand in the cooling products segment. Reduced capacity utilization led to negative operating leverage, resulting in a net loss. Investors should watch for demand revival as the summer season approaches and expect margin normalization from H2 onward.
Windlas Biotech – Q2 FY26 Earnings Highlights
Price: ₹923 | Market Cap: ₹1,950 Cr | PE: 29.0
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹222 Cr | ▲ 19% | ₹187 Cr | ▲ 6% | ₹210 Cr |
| EBITDA | ₹28.6 Cr | ▲ 24% | ₹23.0 Cr | ▲ 8% | ₹26.5 Cr |
| Net Profit | ₹17.8 Cr | ▲ 14% | ₹15.7 Cr | ▲ 1% | ₹17.7 Cr |
| EPS | ₹8.45 | ▲ 13% | ₹7.49 | ▲ 0% | ₹8.43 |
Verdict
Windlas Biotech delivered a steady performance in Q2 with strong year-on-year improvement in revenue, EBITDA, and profitability. Quarter-on-quarter growth remained modest, reflecting stable execution rather than accelerated momentum. Margins are healthy, supported by efficient operations and a solid order book outlook.
Protean eGov – Q2 (Sep 2025) Earnings Highlights
Price: ₹853 | Market Cap: ₹3,463 Cr | PE: 38.0
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹250 Cr | ▲ 14% | ₹220 Cr | ▲ 18% | ₹211 Cr |
| EBITDA | ₹29.3 Cr | ▼ 7% | ₹31.6 Cr | ▲ 79% | ₹16.4 Cr |
| Net Profit | ₹23.9 Cr | ▼ 15% | ₹28.0 Cr | ↔ Flat | ₹23.8 Cr |
| EPS | ₹5.88 | ▼ 15% | ₹6.92 | ↔ Flat | ₹5.88 |
Verdict
Topline growth remained healthy, supported by improved traction across digital e-governance services. However, profitability continues to face pressure on a YoY basis, with margins still softer versus last year. On the brighter side, sequential recovery was strong, particularly in EBITDA, reflecting improving operating leverage and cost efficiencies. Sustained margin expansion will be key for consistent earnings growth ahead.
Linde India – Q2 (Sep 2025) Earnings Highlights
Price: ₹5,843 | Market Cap: ₹49,794 Cr | PE: 98.4
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹644 Cr | ▲ 2% | ₹634 Cr | ▲ 13% | ₹571 Cr |
| EBITDA | ₹282 Cr | ▲ 58% | ₹179 Cr | ▲ 43% | ₹197 Cr |
| Net Profit | ₹169 Cr | ▲ 62% | ₹104 Cr | ▲ 61% | ₹105 Cr |
| EPS | ₹19.82 | ▲ 62% | ₹12.24 | ▲ 61% | ₹12.32 |
Verdict
Linde India reported a strong Q2 performance with sharp margin expansion driving significant profitability growth. Revenue growth remained steady, while cost efficiencies and improved industrial gas demand boosted operating leverage. Earnings momentum remains robust with continued strength in margins.
Aarti Industries – Q2 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹2,100 Cr | ▲ 29% | ₹1,628 Cr | ▲ 25% | ₹1,675 Cr |
| EBITDA | ₹291 Cr | ▲ 48% | ₹197 Cr | ▲ 37% | ₹212 Cr |
| Net Profit | ₹106 Cr | ▲ 68% | ₹52 Cr | ▲ 146% | ₹43 Cr |
| EPS | ₹2.92 | ▲ 104% | ₹1.43 | ▲ 145% | ₹1.19 |
Verdict
Aarti Industries posted a strong earnings rebound in Q2 FY26 aided by higher demand traction, better realizations, and margin expansion. The sharp sequential jump in net profit and EPS reflects improving operational leverage. Sustained demand visibility and consistency in margins remain key factors to monitor in the coming quarters.
JM Financial – Q2 FY26 Earnings Highlights
Price: ₹162 | Market Cap: ₹15,474 Cr | PE: 13.6
JM Financial reported a mixed quarter. While year-on-year profitability improved, quarter-on-quarter numbers softened due to lower deal activity and weaker investment banking flows.
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹1,031 Cr | ▼ 13% | ₹1,191 Cr | ▼ 7% | ₹1,111 Cr |
| EBITDA | ₹605 Cr | ▲ 23% | ₹491 Cr | ▼ 29% | ₹850 Cr |
| Net Profit | ₹262 Cr | ▲ 16% | ₹144 Cr | ▼ 43% | ₹459 Cr |
| EPS | ₹2.82 | ▲ 16% | ₹2.43 | ▼ 41% | ₹4.75 |
Verdict
Profitability improved on a year-on-year basis driven by better operating efficiency and stronger balance sheet utilization. However, the steep quarter-on-quarter decline reflects lower deal flows and reduced market-linked fee income. Sustained profitability ahead will depend on recovery in capital market activity and momentum in the lending & credit businesses.
Genus Power – Q2 (Sep 2025) Earnings Highlights
Price: ₹354 | Market Cap: ₹10,791 Cr | PE: 23.5
Genus Power delivered a strong quarter, supported by robust execution momentum in smart metering orders. Revenues and EBITDA saw sharp year-on-year expansion with stable sequential growth.
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹1,149 Cr | ▲ 136% | ₹487 Cr | ▲ 22% | ₹942 Cr |
| EBITDA | ₹234 Cr | ▲ 188% | ₹81.3 Cr | ▲ 18% | ₹199 Cr |
| Net Profit | ₹143 Cr | ▲ 75% | ₹83.1 Cr | ▲ 4% | ₹137 Cr |
| EPS | ₹4.70 | ▲ 72% | ₹2.73 | ▲ 4% | ₹4.52 |
Verdict
Genus Power continues to benefit from large-scale smart meter project execution and operating leverage. While YoY growth remains exceptionally strong, QoQ momentum indicates stabilization post rapid scaling. Outlook remains healthy with strong order book visibility in the ongoing power distribution digitization cycle.
Pricol Ltd – Q2 FY26 (Sep 2025) Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹1,007 Cr | ▲ 51% | ₹669 Cr | ▲ 13% | ₹895 Cr |
| EBITDA | ₹118 Cr | ▲ 53% | ₹77.2 Cr | ▲ 19% | ₹99 Cr |
| Net Profit | ₹64 Cr | ▲ 42% | ₹45.1 Cr | ▲ 28% | ₹49.9 Cr |
| EPS | ₹5.25 | ▲ 42% | ₹3.70 | ▲ 28% | ₹4.09 |
Verdict
Pricol delivered a strong quarter with robust YoY and QoQ growth across revenue, margins, and bottom-line. Operational leverage and a better product mix supported profitability. Demand from OEMs remains healthy, providing earnings visibility. However, valuations remain elevated at ~33x PE, so the risk-reward now depends on sustaining growth momentum in the coming quarters.
Aster DM Healthcare – Q2 (Sep 2025) Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹1,197 Cr | ▲ 10% | ₹1,086 Cr | ▲ 11% | ₹1,078 Cr |
| EBITDA | ₹236 Cr | ▲ 9% | ₹217 Cr | ▲ 17% | ₹202 Cr |
| Net Profit | ₹121 Cr | ▲ 14% | ₹106 Cr | ▲ 29% | ₹93.6 Cr |
| EPS | ₹2.12 | ▲ 9% | ₹1.94 | ▲ 29% | ₹1.65 |
Verdict
Aster DM delivered healthy growth with strong QoQ improvement in profitability, indicating better operating efficiency and a stable patient mix. YoY performance remained steady. Sustaining margins and volume momentum will be key going forward.
Life Insurance – Q2 (Sep 2025) Earnings Highlights
Price: ₹896 | Market Cap: ₹5,66,345 Cr | PE: 11.1
The company delivered stable performance YoY with improvement in profitability. QoQ trends show mild softening from a strong previous quarter but overall profitability remains resilient.
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹2,41,524 Cr | ▲ 4% | ₹2,31,132 Cr | ▲ 8% | ₹2,24,671 Cr |
| EBITDA | ₹9,492 Cr | ▲ 44% | ₹6,588 Cr | ▼ 9% | ₹10,474 Cr |
| Net Profit | ₹10,096 Cr | ▲ 31% | ₹7,723 Cr | ▼ 8% | ₹10,955 Cr |
| EPS | ₹15.97 | ▲ 31% | ₹12.22 | ▼ 8% | ₹17.32 |
Verdict
Life Insurance posted healthy YoY growth across revenue and profitability, driven by improved underwriting performance and expense discipline. While QoQ numbers eased slightly due to a strong previous quarter, overall profitability remains solid with sustained margin strength. The outlook remains stable backed by steady premium flows and operating leverage.
J Kumar Infra – Q2 (Sep 2025) Earnings Highlights
Price: ₹655 | Market Cap: ₹4,962 Cr | PE: 12.2
The company delivered steady performance YoY, supported by sustained execution in ongoing infrastructure projects. QoQ movement shows mild softening, largely due to seasonal factors and project completion mix.
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹1,337 Cr | ▲ 3% | ₹1,292 Cr | ▼ 10% | ₹1,479 Cr |
| EBITDA | ₹194 Cr | ▲ 3% | ₹188 Cr | ▼ 10% | ₹216 Cr |
| Net Profit | ₹91.5 Cr | ▲ 1% | ₹90.2 Cr | ▼ 11% | ₹103 Cr |
| EPS | ₹12.09 | ▲ 1% | ₹11.92 | ▼ 11% | ₹13.58 |
Verdict
J Kumar Infra reported steady year-on-year growth, maintaining profitability and execution rhythm. The QoQ decline is largely seasonal and margin-neutral, indicating operational stability. With a healthy order book and government infra momentum, the medium-term outlook remains constructively stable.
NHPC Ltd – Q2 (Sep 2025) Earnings Highlights
Price: ₹82.8 | Market Cap: ₹83,282 Cr | PE: 26.3
NHPC reported stable performance YoY, led by consistent hydro power generation. However, sequential (QoQ) softness is visible due to seasonal factors and lower water availability during the monsoon transition period.
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹2,732 Cr | ▲ 7% | ₹2,549 Cr | ▼ 8% | ₹2,977 Cr |
| EBITDA | ₹1,518 Cr | ▲ 6% | ₹1,431 Cr | ▼ 8% | ₹1,646 Cr |
| Net Profit | ₹926 Cr | ▲ 3% | ₹898 Cr | ▼ 14% | ₹1,072 Cr |
| EPS | ₹0.92 | ▲ 3% | ₹0.89 | ▼ 14% | ₹1.07 |
Verdict
NHPC delivered a steady year-on-year performance, reflecting long-term stability in its regulated hydro portfolio. The quarter-on-quarter decline is seasonal, not structural. The company continues to benefit from robust hydropower demand, execution progress in under-construction projects, and clean energy transition tailwinds.
Bajaj Housing Finance – Q2 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base |
|---|---|---|---|
| Revenue | ₹2,755 Cr | ▲ 14.3% | ₹2,409 Cr |
| Net Interest Income (NII) | ₹956 Cr | ▲ 34% | ₹713 Cr |
| PAT | ₹643 Cr | ▲ 17.8% | ₹546 Cr |
| Net Profit Margin | 23.34% | ▲ 0.7 pts | 22.6% |
| AUM | ₹1.27 Lakh Cr | ▲ 24% | ₹1.02 Lakh Cr |
| Loan Assets | — | ▲ 26% | — |
| Gross NPA | 0.26% | ▼ (Improved from 0.29%) | 0.29% |
| Net NPA | 0.12% | No Change | 0.12% |
| ROA | 2.3% | ▼ (from 2.5%) | 2.5% |
| Loan Losses & Provisions | ₹50 Cr | ▲ ~10x YoY | ~₹5 Cr |
| CAR (Capital Adequacy Ratio) | 26.12% | ▼ 2.86 pts | 28.98% |
| Debt-to-Equity | 4.44 | ▲ (Leveraging Continues) | — |
Verdict
Bajaj Housing Finance delivered a strong quarter with solid growth in AUM, revenue, and NII, driven by healthy loan disbursement and stable spreads. Asset quality remained robust with improvement in gross NPAs. However, elevated provisions and a mild decline in ROA indicate cautious risk management during its expansion cycle. Overall, operational momentum remains strong and the balance sheet stays comfortably capitalized.







